Neurocritical Care Society (NCS) 23rd Annual Meeting September 18th-21st, 2025 in Montreal, Canada
Hemedex is pleased to announce that we will be a featured exhibitor at the Neurocritical Care Society 23rd Annual Meeting at Booth 502, September 18th-21st, 2025, in Montreal, Canada.
A Lunch Symposium, “Pressure, Volume, and Flow: Filling in the Missing Piece of Brain Physiology in Multimodality Neuromonitoring”, given by guest speaker, Dr. Brandon Foreman from the University of Cincinnati will be held on Friday, September 19th, 12:15pm – 1:15pm EDT at the Montreal Convention Centre. The talk will discuss how cerebral blood flow monitoring as a key to interpreting multimodality neuromonitoring and understanding the secondary pathophysiologies that develop after severe acute brain injury.
The NCS Annual Meeting is the only national conference that focuses specifically on the practice of neurocritical care across all specialties. The Neurocritical Care Society is an international, multidisciplinary medical society first established in 2002. With more than 2,500 members worldwide, the mission of the Neurocritical Care Society is to improve outcomes for patients with life-threatening neurological illnesses. For more information about the Neurocritical Care Society Annual Meeting, visit http://www.neurocriticalcare.org.
To schedule a webinar with us, email salesteam@hemedex.com.
Neurocritical Care Society (NCS) 22nd Annual Meeting October 14th-18th, 2024 in San Diego, California.
Hemedex is pleased to announce that they will be a featured exhibitor at the Neurocritical Care Society 22nd Annual Meeting at Booth 518, October 14th-18th, 2024, virtually and in San Diego, California. The NCS Annual Meeting is the only national conference that focuses specifically on the practice of neurocritical care across all specialties. The Neurocritical Care Society is an international, multidisciplinary medical society first established in 2002. With more than 2,500 members worldwide, the mission of the Neurocritical Care Society is to improve outcomes for patients with life-threatening neurological illnesses. For more information about the Neurocritical Care Society, visit http://www.neurocriticalcare.org.
To schedule a webinar with us, email salesteam@hemedex.com.
Neurocritical Care Society (NCS) 21st Annual Meeting August 15th – 18th, 2023 in Phoenix, Arizona
Hemedex is pleased to announce that they will be a featured exhibitor at the Neurocritical Care Society 21st Annual Meeting, August 15-18, 2023, virtually and at Booth 417 and Poster 188 in Phoenix, Arizona. The NCS Annual Meeting is the only national conference that focuses specifically on the practice of neurocritical care across all specialties. The Neurocritical Care Society is an international, multidisciplinary medical society first established in 2002. With more than 2,500 members worldwide, the mission of the Neurocritical Care Society is to improve outcomes for patients with life-threatening neurological illnesses. For more information about the Neurocritical Care Society, visit http://www.neurocriticalcare.org.
For more information on Poster 188: “Brain tissue thermal conductivity-based regional quantitative brain edema values after severe traumatic brain injury”: Please follow the link to the Hemedex YouTube page where you can find a brief discussion by Dr. Brandon Foreman of University of Cincinnati.
Neurocritical Care Society (NCS) 20th Annual Meeting October 17th – 20th, 2022, in San Antonio, Texas
Hemedex attended the Neurocritical Care Society (NCS) 20th Annual Meeting October 17th – 20th in San Antonio, Texas. For twenty years, the Neurocritical Care Society has brought together neurocritical care professionals, leading research, accomplished speakers and industry partners for the NCS Annual Meeting.
NCS 20th Annual Meeting attendees participated in four days full of innovative education and unique networking opportunities including:
- In-depth education sessions covering the latest advances and challenges facing neurocritical care today.
- Accomplished speakers poised to deliver relevant content on trending research and findings.
- Access to industry partners for an inside look at future medical advancements and technology.